Zubayr Hamza of South Africa has been charged under the International Olympic Committee’s Anti-Doping Code after testing positive for a prohibited substance

Under the ICC Anti-Doping Code, Zubayr Hamza, a South African batter, has been charged for violating an anti-doping regulation, according to the International Cricket Council (ICC). Following the discovery of Furosemide in a sample collected out-of-competition on January 17, 2022, Hamza has been charged with the presence and/or use of a prohibited substance. Hamza has agreed to a temporary suspension awaiting the result of the disciplinary process.

Under the International Cricket Council (ICC) anti-doping Test, which was conducted on March 17, 2022, Hamza had tested positive for a banned drug. Furosemide is a Specified Substance that is listed in Section S5 of the World Anti-Doping Agency’s Prohibited List for 2022. However, the drug in question is not a performance-enhancing agent, but rather a diuretic, which is used to treat hypertension and reduce swelling produced by fluid accumulation in the body. The International Criminal Court will make no additional remark at this time because the procedures are still ongoing.

As of now, Hamza has only played six Tests for his country, scoring a single half-century in 12 innings. He made his Test debut against Pakistan in 2019. In 2021, he made his One-Day International debut against the Netherlands, scoring a half-century on his way to the victory.